Just when you thought bluebird bio was singing, it flapped its wings and flew to into the trees
IPO receptivity unfolds … again Read more…
IPO receptivity unfolds … again Read more…
The 6 W’s: Who, what, where, when, why and what of it Read more…
A gene therapy platform Read more…
Which RegMed companies are making moves in the 1st hour? Read more…
Market waits for Bernanke’s briefing at 2:30 p.m. Read more…
We are in a weird time for the RegMed and cell therapy sectors Read more…
The 6 W’s: Who, what, where, when, why and what of it Read more…
Which RegMed companies are making moves in the 1st hour? Read more…
To fund further clinical development of Tcelna and the P2b study in patients with SPMS Read more…
Stock futures are higher ahead of housing data and Fed policy meet Read more…

Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.